Leidos Wins $317.9 Million US Defense Health Agency Contract

Leidos has secured a $317.9 million contract with the US Defense Health Agency. The company's stock is currently trading at $119.70, with a 5-day change of -1.56%. Goldman Sachs recently adjusted its price target for Leidos to $127 from $132.

Original reporting
Published Oct 13, 2026, 9:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$LDOS
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

High
01

Why it matters

The award adds a sizable, multi‑year revenue stream, likely improving earnings guidance and investor sentiment.

02

Market read

A new $317.9 M defense contract is a material catalyst for Leidos and may lift the broader defense sector.

03

What to watch

Potential cost overruns or future budget cuts could temper upside.

Relevance 7/10Novelty 9/10Timing: after‑hours

Background

Leidos (LDX) is a major U.S. defense and IT services firm; the Defense Health Agency contract supports medical IT systems for the military.

Market effects

Boosts outlook for the defense and government‑contracting sector.

U.S. defense contractors may see modest gains.

Limited to defense‑related equities; no broad market effect.

Counterpoint

If the contract faces execution risk, the stock could be over‑priced on hype.

Key entities

  • Leidos Holdings, Inc.

    U.S. defense contractor and IT services provider.

  • U.S. Defense Health Agency

    Federal agency overseeing health services for the armed forces.

Related articles

$LDOSMedAI 9/10

Blackstone Credit & Insurance Led a $1 Billion Private Financing for the Combination of Analogic and Leidos’ Security Businesses:

Blackstone Credit & Insurance led a $1 billion financing for the merger of Analogic and Leidos' security businesses, creating a larger security imaging company. BXCI, HPS, Bank of America, and Wells Fargo served as lenders. Analogic is backed by Altaris, with Leidos retaining a 41.5% stake. The deal reflects a trend in private credit financing for larger, defensive loans in security and defense-adjacent sectors.

$LDOSMed

Blackstone’s insurance-focused credit arm leads $1 billion loan for security imaging combination

Blackstone Credit & Insurance (BXCI) led a $1 billion loan for the combination of Analogic Corporation with three Leidos businesses, forming a company specializing in imaging and detection technology. BXCI acted as lead lender alongside HPS, Bank of America, and Wells Fargo. Analogic, based in New Hampshire, supplies advanced imaging technology, while Leidos, based in Virginia, reported $17.2 billion in revenue for 2026.

$LDOSHighAI 9/10

Blackstone Credit & Insurance Leads $1 Billion Financing For Analogic And Leidos Security Businesses Combination

Blackstone Credit & Insurance led a $1 billion financing for the combination of Analogic Corporation and Leidos Holdings' security businesses. The transaction, closed in October 2026, creates a larger global security imaging and detection company. Analogic is based in Salem, New Hampshire, and serves various markets with advanced imaging and detection solutions. Leidos reported $17.2 billion in annual revenue for the fiscal year ended January 2, 2026.

$LDOSHighAI 9/10

Blackstone Leads $1B Loan for Leidos-Analogic Deal

Blackstone is leading a $1B private credit package for Leidos' acquisition of Analogic, with Bank of America and Wells Fargo as joint arrangers. Leidos, a publicly traded company, reported $17.2B in 2025 revenue. The deal highlights strong lending in AI and security sectors.